Salanersen was generally well-tolerated, slowed neurodegeneration, and enabled functional gains
Huwel’s diagnostic solutions leverage open RT-PCR system
Indian companies must make their own intermediates and support small industries: Dr. K. Nagaiah, Chief Scientist, CSIR - IICT, Hyderabad
Itvisma is a one-time, fixed-dose therapy designed to tackle the genetic root cause of SMA
HER2-mutant NSCLC typically has a poor prognosis and limited treatment options
Over 700 exhibitors from APAC, Europe, the US, and beyond showcased the latest in personal care innovation
This predictive technology empowers people with diabetes to take preventive action before complications arise
The study further confirmed that GAL-101 effectively crosses the blood-brain barrier
First and only TROP2-directed therapy approved in the US for the treatment of lung cancer
Subscribe To Our Newsletter & Stay Updated